Triggering memory B cells directly in lungs seen as way to improve vaccines
How can the efficacy of vaccines used to protect against viral respiratory diseases such as influenza and COVID-19 be increased? The triggering of memory B cells directly in the lungs could be a promising method, according to scientists. Read More
PrecisionLife, Sano Genetics partner on studying long COVID
PrecisionLife is joining forces with Sano Genetics to better understand the long-term effects of the coronavirus (long COVID). PrecisionLife’s proprietary combinatorial analytics platform will identify risk factors and potential drug targets by analyzing Sano Genetics’ data from 3,000 U.K. adults suffering from long COVID symptoms. Read More
How has the COVID-19 pandemic affected pediatric care?
What impact has the COVID-19 pandemic had on the care of pediatric cancer patients internationally? It depends on the country, according to Dr. Muhammed Elhadi of the University of Tripoli in Libya. Elhadi spoke with ScienceBoard.net at the recent American Association for Cancer Research meeting in New Orleans. Read More
CoVac-1 vaccine shows promise for immunocompromised patients
At the recent American Association for Cancer Research meeting in New Orleans, ScienceBoard.net spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 vaccine has shown in immunocompromised patients. Read More
COVID-19 protects unvaccinated from reinfection
Unvaccinated people who have a previous COVID-19 infection have a level of protection from future infections that's comparable to protection provided by mRNA vaccines, according to a new study published on April 20 in JAMA Network Open. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter